Overview
Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand
Status:
Completed
Completed
Trial end date:
2012-12-01
2012-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this study is to evaluate the conversion of OP to OC in individual X and the family member of individual X. The investigators hypothesize that one or more of the single nucleoprotein polymorphisms (SNPs) of the CES1 gene represent a clinically important functional polymorphism.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University of OxfordCollaborator:
South East Asia Infectious Disease Clinical Research NetworkTreatments:
Oseltamivir
Criteria
Inclusion Criteria:- Signed informed consent
- Healthy family member of individual X and individual X
- Aged between 18 and 70, inclusive.
Exclusion Criteria:
- known allergy to oseltamivir
- any underlying illness that is considered a risk to the health of the individual
- pregnant
- breast feeding
- creatinine clearance < 30 mL/min calculated by the Cockcroft Gault formula: CrCl
(ml/min) = (140-age) x Wt in kg / creatinine mg/dL x 72, for females, the result is
multiplied by 0.85.